Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: Results from the prospective, randomized proBNP outpatient tailored chronic heart failure therapy (PROTECT) study

Journal of Cardiac Failure

Volumn 18, Issue 8, 2012, Pages 626-634

  Gaggin, Hanna K ^a   Mohammed, Asim A ^a   Bhardwaj, Anju ^a   Rehman, Shafiq U ^a   Gregory, Shawn A ^a   Weiner, Rory B ^a   Baggish, Aaron L ^a   Moore, Stephanie A ^a   Semigran, Marc J ^a   Januzzi Jr , James L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

age; biomarker; Natriuretic peptides; outcomes

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AGED; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE QUALITY; HEART FAILURE; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84864453622     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.05.005     Document Type: Article

References (30)

1. J.J. McMurray, M.C. Petrie, D.R. Murdoch, and A.P. Davie Clinical epidemiology of heart failure: public and private health burden Eur Heart J 19 Suppl P 1998 P9 P16
2. G.S. Bleumink, A.M. Knetsch, and M.C. Sturkenboom Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study Eur Heart J 25 2004 1614 1619
3. A. Mosterd, and A.W. Hoes Clinical epidemiology of heart failure Heart 93 2007 1137 1146
4. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
5. M.D. Flather, M.C. Shibata, and A.J. Coats Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225
6. F. Tehrani, A. Phan, and C.V. Chien Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction Am J Cardiol 103 2009 829 833
7. J.L. Januzzi Jr., C.A. Camargo, and S. Anwaruddin The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study Am J Cardiol 95 2005 948 954
8. J.L. Januzzi Jr., R. Sakhuja, and M. O'Donoghue Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department Arch Intern Med 166 2006 315 320
9. A. Sachdeva, T.B. Horwich, and G.C. Fonarow Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure Am J Cardiol 106 2010 830 835
10. M. Yoshimura, Y. Mizuno, and M. Nakayama B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure Am J Med 112 2002 716 720
11. R. Latini, S. Masson, and I. Anand Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT) Circulation 106 2002 2454 2458
12. B. Stanek, B. Frey, and M. Hulsmann Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction J Am Coll Cardiol 38 2001 436 442
13. J.W. Fung, C.M. Yu, and G. Yip Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure Am J Cardiol 92 2003 406 410
14. C. Berry, N.F. Murphy, and G. De Vito Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker Eur J Heart Fail 9 2007 429 434
15. R. Berger, D. Moertl, and S. Peter N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study J Am Coll Cardiol 55 2010 645 653
16. P. Jourdain, G. Jondeau, and F. Funck Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study J Am Coll Cardiol 49 2007 1733 1739
17. M. Pfisterer, P. Buser, and H. Rickli BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial JAMA 301 2009 383 392
18. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial J Am Coll Cardiol 55 2009 53 60
19. A. Bhardwaj, S.U. Rehman, and A. Mohammed Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study Am Heart J 159 2010 532 538.e1
20. J.L. Januzzi Jr., S.U. Rehman, and A.A. Mohammed Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
21. S. Masson, R. Latini, and I.S. Anand Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
22. O. Garin, M. Ferrer, and A. Pont Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses Qual Life Res 18 2009 71 85
23. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
24. J.A. Hanley, A. Negassa, M.D. Edwardes, and J.E. Forrester Statistical analysis of correlated data using generalized estimating equations: an orientation Am J Epidemiol 157 2003 364 375
25. D.E. Forman, M.W. Rich, and K.P. Alexander Cardiac care for older adults: time for a new paradigm J Am Coll Cardiol 57 2011 1801 1810
26. A.P. Maggioni, G. Sinagra, and C. Opasich Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience Heart 89 2003 299 305
27. W.F. Gellad, J.L. Grenard, and Z.A. Marcum A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity Am J Geriatr Pharmacother 9 2011 11 23
28. G.M. Felker, V. Hasselblad, A.F. Hernandez, and C.M. O'Connor Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 2009 422 430
29. P. Porapakkham, H. Zimmet, B. Billah, and H. Krum B-type natriuretic peptide-guided heart failure therapy: a meta-analysis Arch Intern Med 170 2010 507 514
30. T.B. Levine, A.B. Levine, J. Bolenbaugh, and P.R. Green Reversal of heart failure remodeling with age Am J Geriatr Cardiol 11 2002 299 304